Explore more publications!
Health Insider Virgin Islands
Got News to Share?

Health Insider Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Insider Virgin Islands.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on November 6, 2025

Denali Therapeutics Announces Board and Executive Leadership Updates
November 6, 2025

Denali Therapeutics Announces Board and Executive Leadership Updates

Indeterminate GlobeNewswire
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 6, 2025

IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire
Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates
November 6, 2025

Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates

Indeterminate GlobeNewswire
FDA Awards Second Batch of National Priority Vouchers
November 6, 2025

FDA Awards Second Batch of National Priority Vouchers

Indeterminate GlobeNewswire
Announcing the Dr. Austin Harris Grant for Student Athletes: A New Initiative Supporting Academic and Athletic Excellence
November 6, 2025

Announcing the Dr. Austin Harris Grant for Student Athletes: A New Initiative Supporting Academic and Athletic Excellence

Indeterminate GlobeNewswire
Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
November 6, 2025

Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer

Indeterminate GlobeNewswire
Global Oxygen Therapy Equipment Market is Predicted to Surge at ~8% CAGR by 2032 Owing to the Rising Respiratory Disorders and Technological Advancements | DelveInsight
November 6, 2025

Global Oxygen Therapy Equipment Market is Predicted to Surge at ~8% CAGR by 2032 Owing to the Rising Respiratory Disorders and Technological Advancements | DelveInsight

Indeterminate GlobeNewswire
Corza Medical Launches Customer Portal to Enhance the Digital Ordering Experience for Eye Care Professionals
November 6, 2025

Corza Medical Launches Customer Portal to Enhance the Digital Ordering Experience for Eye Care Professionals

Indeterminate GlobeNewswire
Women in Health Administration Announces 2026 Woman of the Year: Anne Tanner, MN, RN, NEA-BC, FACHE
November 6, 2025

Women in Health Administration Announces 2026 Woman of the Year: Anne Tanner, MN, RN, NEA-BC, FACHE

Indeterminate GlobeNewswire
Elixir Medical Highlights Results From “Real World” MY-IVL Study Demonstrating Performance of LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Treating Calcified Coronary Lesions
November 6, 2025

Elixir Medical Highlights Results From “Real World” MY-IVL Study Demonstrating Performance of LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Treating Calcified Coronary Lesions

Indeterminate GlobeNewswire
Zealand Pharma conference call on November 13 at 2pm CET (8am ET) to present third quarter 2025 financial results
November 6, 2025

Zealand Pharma conference call on November 13 at 2pm CET (8am ET) to present third quarter 2025 financial results

Indeterminate GlobeNewswire
Genmab Announces Financial Results for the Nine Months of 2025
November 6, 2025

Genmab Announces Financial Results for the Nine Months of 2025

Indeterminate GlobeNewswire
Channel Medsystems Surpasses 5,000 Cerene® Cryotherapy Procedures, Marking Milestone in Women’s Health Innovation
November 6, 2025

Channel Medsystems Surpasses 5,000 Cerene® Cryotherapy Procedures, Marking Milestone in Women’s Health Innovation

Indeterminate GlobeNewswire
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
November 6, 2025

ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025

Indeterminate GlobeNewswire
LTC ACO Demonstrates Continued Strength, Completing All 2024 Provider Payments
November 6, 2025

LTC ACO Demonstrates Continued Strength, Completing All 2024 Provider Payments

Indeterminate GlobeNewswire
Novel Pipeline Activity Signals Hope in Systemic Sclerosis, as Rheumatologists Anticipate First Real Therapeutic Advances in Years
November 6, 2025

Novel Pipeline Activity Signals Hope in Systemic Sclerosis, as Rheumatologists Anticipate First Real Therapeutic Advances in Years

Indeterminate GlobeNewswire
Vera Therapeutics Announces Positive ORIGIN Phase 3 Data for Atacicept in IgA Nephropathy Presented at ASN Kidney Week 2025 and Published in the New England Journal of Medicine
November 6, 2025

Vera Therapeutics Announces Positive ORIGIN Phase 3 Data for Atacicept in IgA Nephropathy Presented at ASN Kidney Week 2025 and Published in the New England Journal of Medicine

Indeterminate GlobeNewswire
Porch Light Health Launches Advanced Drug Lab to Improve Patient Safety and Spot Dangerous Drug Trends in Our Communities
November 6, 2025

Porch Light Health Launches Advanced Drug Lab to Improve Patient Safety and Spot Dangerous Drug Trends in Our Communities

Indeterminate GlobeNewswire
Pennant Group to Participate in the 2025 Stephens Annual Investment Conference
November 6, 2025

Pennant Group to Participate in the 2025 Stephens Annual Investment Conference

Indeterminate GlobeNewswire
PharmaCorp Announces Upsized C$20 Million Bought Deal Public Offering
November 6, 2025

PharmaCorp Announces Upsized C$20 Million Bought Deal Public Offering

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions